Beyond Biotech - the podcast from Labiotech
Welcome to the official Labiotech.eu podcast - Beyond Biotech! Each week, we talk about what's happening in the world of biotech, with news and interviews with experts from companies around the world. Join us as we cover the latest news, breakthroughs and innovations shaping the life sciences industry.A new podcast episode is available every Friday. The host is Dylan Kissane.
Beyond Biotech - the podcast from Labiotech
The problem at the heart of drug discovery: Lexogen & Ochre Bio on the power of AI on human data
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
Today I am welcoming two guests: Quin Wills, CEO of Ochre Bio, a biotech developing RNA therapies for chronic liver disease using AI models, and Stéphane Barges, CEO of Lexogen, an RNA transcriptomics company and NGS service provider. It’s a deep dive into cutting edge transcriptomics, human-first data, and artificial intelligence.
00:55: The challenges of liver disease
04:44: How Lexogen supports NGS drug discovery
07:29: Major transcriptomics developments
10:05: Designing high quality AI data
15:47: How the Ochre-Lexogen partnership began
17:17: Why a specialist partner is essential for scale
18:21: Lexogen delivers on the massive sequencing project
21:50: Why high quality data is crucial
27:02: Lexogen's role in AI discovery
34:51: Future plans and directions
This episode was produced with the support of Lexogen. Interested in being a sponsor of an episode of our podcast? Discover how you can get involved here!
Stay updated by subscribing to our newsletter
To dive deeper into the topic: